Adding exenatide to insulin treatment in patients with type 2 diabetes

Posted by Medivizor on Nov 8, 2020 in Diabetes mellitus |

Email

In a nutshell

This controlled trial looked at adding exenatide (Byetta) to intensive insulin treatment for patients with type 2 diabetes (T2D) who still had high blood sugar. It found that the exenatide improved blood sugar control and reduced body weight in these patients.

Some background

T2D is a metabolic condition in which the body does not respond well to the hormone insulin, which…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *